This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Bausch-Lomb Incorporated. Active years: 2006-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sierksdorf, DE (2006)
- Sterksdorf, DE (2007)
Company Filing History:
Years Active: 2006-2007
Title: Innovations by Hans Hoerauf in Ophthalmology
Introduction
Hans Hoerauf is a notable inventor based in Sierksdorf, Germany. He has made significant contributions to the field of ophthalmology, holding a total of 2 patents. His work focuses on innovative methods and materials that enhance the safety and effectiveness of ocular treatments.
Latest Patents
One of his latest patents is a method for the passivation of an intraocular lens. This invention includes a technique for treating the surface of an intraocular lens that contains Brønsted sites. The lens is immersed in a solution of a fluoroalkyl silane, which helps deactivate the Brønsted sites by forming Si—Q—bonds. Another significant patent involves the utilization of a highly fluorinated oligomeric alkane as a therapeutic agent in ophthalmology. This alkane is designed to minimize damage to the retina, even with prolonged use, making it a valuable pharmacological agent in eye care.
Career Highlights
Hans Hoerauf is currently associated with Bausch + Lomb Incorporated, a leading company in the field of eye health. His work at this organization has allowed him to further develop his innovative ideas and contribute to advancements in ophthalmic treatments.
Collaborations
Throughout his career, Hans has collaborated with esteemed colleagues such as Joachim Dresp and Udo Gross. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field.
Conclusion
Hans Hoerauf's contributions to ophthalmology through his patents and collaborations highlight his commitment to improving eye health. His innovative approaches continue to pave the way for advancements in the treatment of ocular conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
